Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-31 Schoenberg Mark Chief Medical Officer Exercise or conversion +2,000 21,831
2021-01-31 Schoenberg Mark Chief Medical Officer Sale −1,076 $22.07 $24K 20,755
2021-01-31 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −2,000 4,000
2021-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Stock Option (right to buy) +21,000 21,000
2021-01-31 Schoenberg Mark Chief Medical Officer Grant or award · Restricted Stock Units +6,000 6,000
2021-01-26 Schoenberg Mark Chief Medical Officer Exercise or conversion +208 19,931
2021-01-26 Schoenberg Mark Chief Medical Officer Sale −100 $22.12 $2K 19,831
2021-01-26 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −208 834
2021-01-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,807 237,924
2021-01-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,807 105,689
2020-12-14 Barrett Elizabeth A. Chief Executive Officer Purchase +10,000 $18.50 $185K 229,117
2020-12-04 Schoenberg Mark Chief Medical Officer Exercise or conversion +1,042 20,385
2020-12-04 Schoenberg Mark Chief Medical Officer Sale −662 $19.85 $13K 19,723
2020-12-04 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units −1,042 0
2020-12-04 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +61,652 219,117
2020-12-04 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −61,652 114,496
2020-12-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,808 219,117
2020-12-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,808 114,496
2020-11-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion +8,808 210,309
2020-11-03 Barrett Elizabeth A. Chief Executive Officer Exercise or conversion · Restricted Stock Units −8,808 123,304

Page 18 of 25 · 496 trades